Gillette India Limited (GILLETTE)

Fast Moving Consumer Goods · Personal Products · NSE · Updated 16 June 2026
₹7,722.5 ↓ 23.81% (1Y)

🎯 Key Takeaways

  • Gillette India Limited is in a mature phase with signs of stabilization but ongoing pressure, as reflected by its declining one-year return of -23.81% and a P/E of 41.
  • ⚠️ Sustained underperformance in share price (-23.81% one-year return) despite mature market positioning raises concerns about declining competitiveness
Market Cap
₹25,438
P/E Ratio
41.0
Div Yield
0.00%
Promoter
0.0%

📖 The Story

Gillette India Limited is in a mature phase with signs of stabilization but ongoing pressure, as reflected by its declining one-year return of -23.81% and a P/E of 41.0, suggesting market skepticism about near-term recovery. The company operates in the personal products segment within FMCG, where growth is typically steady but limited, and recent regulatory actions indicate routine compliance focus rather than strategic transformation. Management has not signaled a new growth catalyst, and the business appears to be navigating a plateau with limited upside potential in the current environment.

📰 What's Happening

The most recent disclosed event was the closure of the insider trading window effective April 1, 2026, ahead of the release of audited financial results for Q4 and FY2026 ending March 31, 2026. This regulatory measure underscores standard governance practices but does not indicate operational or strategic shifts. No board-level initiatives or management changes were reported in the June 12, 2026 board meeting filing, suggesting continuity in leadership and no immediate strategic recalibration.

Source: Stock Announcements

🔮 Management Outlook & What's Next

Management has not provided forward-looking guidance or strategic commentary in the available filings. The only forward reference is procedural, relating to the reopening of the trading window after the publication of audited financial statements for Q4 and FY2026. No commentary on demand trends, margin expectations, or investment plans was included in the disclosed materials.

Extracted from official company announcements. Not StockFin.ai's opinion.

⚖️ Peer Comparison — Personal Products

Company MCap (₹ Cr) P/E ROCE ROE D/E
Godrej Consumer Products Limited 1.06 L Cr -234.6
Dabur India Limited 82,955 46.1
Colgate Palmolive (India) Limited 58,749 44.3
Procter & Gamble Hygiene and Health Care Limited 31,506 36.7
Gillette India Limited 25,438 41.0
Emami Limited 18,684 23.6
Cupid Limited 16,184 668.7
Honasa Consumer Limited 11,518 145.1
Bajaj Consumer Care Limited 7,020 58.5
JHS Svendgaard Laboratories Limited 80 -5.8

🔗 Peer Stock Analyses

GODREJCPDABURCOLPALPGHHEMAMILTD

⚠️ Risk Factors

1. Sustained underperformance in share price (-23.81% one-year return) despite mature market positioning raises concerns about declining competitiveness or demand erosion. 2. High P/E of 41.0 in a stagnant or declining operational context may reflect market pricing of unmet growth expectations, increasing vulnerability to earnings misses or negative sentiment shifts.

🧠 Analyst's Read

The company appears to be in a holding pattern, with no clear catalyst emerging from recent disclosures. Investors should monitor the upcoming audited financial results for signs of margin stability, volume trends, or any strategic updates, as these will likely determine near-term market direction for GILLETTE.

Based on filing content and financial data. Not a recommendation.

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-06-16.